These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 824932)

  • 21. Enzyme transplantation in Fabry's disease.
    Krivit W; Desnick RJ; Bernlohr RW; Wold F; Najarian JS; Simmons RL
    N Engl J Med; 1972 Dec; 287(24):1248-9. PubMed ID: 4563680
    [No Abstract]   [Full Text] [Related]  

  • 22. [Enzyme replacement therapy in Fabry's disease].
    Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
    Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation.
    Mosnier JF; Degott C; Bedrossian J; Molas G; Degos F; Pruna A; Potet F
    Transplantation; 1991 Apr; 51(4):759-62. PubMed ID: 1849671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Visceral manifestations of glycosphingolipidosis (Fabry's disease)].
    Zaĭrat'iants OV; Bruk EI; Berestova AV; Mendel'son MM
    Arkh Patol; 1987; 49(6):58-63. PubMed ID: 3117021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isolation and identification of products of accumulation in Fabry disease].
    Baskaeva EM; Diatlovitskaia EV; Vidershaĭn GIa
    Vopr Med Khim; 1988; 34(6):94-8. PubMed ID: 3149074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of renal ectopia with Fabry's disease in 3 patients.
    Rákóczi E; Tóth B; Görögh S; Erdos M; Sümegi J; Maródi L
    J Urol; 2009 Apr; 181(4):1949-54. PubMed ID: 19237168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
    Germain DP
    J Soc Biol; 2002; 196(2):183-90. PubMed ID: 12360747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac transplantation for Fabry's disease.
    Cantor WJ; Daly P; Iwanochko M; Clarke JT; Cusimano RJ; Butany J
    Can J Cardiol; 1998 Jan; 14(1):81-4. PubMed ID: 9487277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light- and electron-microscopic histochemistry of Fabry's disease.
    Faraggiana T; Churg J; Grishman E; Strauss L; Prado A; Bishop DF; Schuchman E; Desnick RJ
    Am J Pathol; 1981 May; 103(2):247-62. PubMed ID: 6786101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of Fabry's disease with normal kidney function at 10 years after successful renal transplantation.
    Erten Y; Ozdemir FN; Demirhan B; Karakayali H; Demirağ A; Akkoç H
    Transplant Proc; 1998 May; 30(3):842-3. PubMed ID: 9595121
    [No Abstract]   [Full Text] [Related]  

  • 31. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote.
    Rietra PJ; Van den Bergh FA; Tager JM
    Clin Chim Acta; 1975 Aug; 62(3):401-13. PubMed ID: 809216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The general review on Fabry's disease].
    Grosshans E
    Ann Dermatol Venereol; 1986; 113(3):277. PubMed ID: 3092719
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytoplasmic inclusions of Fabry's disease. Ultrastructural demonstration of their presence in urine sediment.
    Tubbs RR; Gephardt GN; McMahon JT; Hall PM; Gifford RW
    Arch Pathol Lab Med; 1981 Jul; 105(7):361-2. PubMed ID: 6264885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bronchiolitis obliterans organizing pneumonia in a kidney transplantation patient with Fabry's disease].
    Gómez Belda AB; Rovira Daudí E; Julve Pardo R; Belda Mira A
    Rev Clin Esp; 1999 Mar; 199(3):187-8. PubMed ID: 10230307
    [No Abstract]   [Full Text] [Related]  

  • 35. Fabry's disease.
    Adam T; Alexandrescu L; Voinea F; Toringhibel M; Hâncu A
    Rom J Intern Med; 2006; 44(4):455-64. PubMed ID: 18386622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postmortem diagnosis of Fabry disease in a female heterozygote leading to the detection of undiagnosed manifest disease in the family].
    Hůlková H; Ledvinová J; Poupĕtová H; Bultas J; Zeman J; Elleder M
    Cas Lek Cesk; 1999 Nov; 138(21):660-4. PubMed ID: 10746023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of Fabry's disease.
    Miura M; Tomino Y; Inoue W; Endoh M; Suga T; Kaneshige H; Nomoto Y; Sakai H; Matsuo I; Nagura H; Ikeda N
    Tokai J Exp Clin Med; 1983 Jan; 8(1):23-9. PubMed ID: 6310828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells.
    Takenaka T; Murray GJ; Qin G; Quirk JM; Ohshima T; Qasba P; Clark K; Kulkarni AB; Brady RO; Medin JA
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7515-20. PubMed ID: 10840053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies.
    Desnick RJ; Blieden LC; Sharp HL; Hofschire PJ; Moller JH
    Circulation; 1976 Nov; 54(5):818-25. PubMed ID: 824066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosphingolipids and kidney disease.
    Mather AR; Siskind LJ
    Adv Exp Med Biol; 2011; 721():121-38. PubMed ID: 21910086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.